Saluvet innova INGLES
  • HOME
  • SERVICES & PRODUCTS
    • DIAGNOSTIC REAGENTS >
      • ANTIGENS AND OTHER DIAGNOSTIC REAGENTS
      • CONTROL SERA
    • DIAGNOSTIC SERVICE >
      • BOVINE (AGENTS)
      • BOVINE (PANELS)
      • OTHER SPECIES
    • ANIMAL MODELS >
      • MODELS OF NEOSPOROSIS
      • MODELS OF TOXOPLASMOSIS
      • MODELS OF CRYPTOSPORIDIOSIS
    • DRUG SCREENING
    • TECHNICAL ADVICE AND DEVELOPMENT OF NEW PRODUCTS
  • R+D+I
    • DEVELOPMENT OF VACCINES
    • DIVA VACCINES
    • IN VITRO AND IN VIVO MODELS & DRUG SCREENING
  • NEWS
  • WHO ARE WE?
  • CONTACT US
  • ESPAÑOL
Picture

MOUSE MODEL

Model developed in non-consanguineous mouse (Mus musculus) strains infected by Toxoplasma gondii oocysts.

Uses: Efficacy of new drugs and vaccines as "proof of concept".
toxoratónmuller_et_al._2017.pdf
File Size: 424 kb
File Type: pdf
Descargar archivo

FELINE MODEL

Model developed in the definitive host (Felis silvestris catus).
 
Uses: Production of oocysts. Evaluation of drugs and vaccines.
Picture
Picture

PREGNANT OVINE MODEL

Model developed in pregnant sheep (Ovis aries) based on challenge with oocysts * during the second third of gestation.
 
Uses: Evaluation of drugs and vaccines.
CONTACT US
By sending the data you accept our privacy policy
Con tecnología de Crea tu propio sitio web único con plantillas personalizables.
  • HOME
  • SERVICES & PRODUCTS
    • DIAGNOSTIC REAGENTS >
      • ANTIGENS AND OTHER DIAGNOSTIC REAGENTS
      • CONTROL SERA
    • DIAGNOSTIC SERVICE >
      • BOVINE (AGENTS)
      • BOVINE (PANELS)
      • OTHER SPECIES
    • ANIMAL MODELS >
      • MODELS OF NEOSPOROSIS
      • MODELS OF TOXOPLASMOSIS
      • MODELS OF CRYPTOSPORIDIOSIS
    • DRUG SCREENING
    • TECHNICAL ADVICE AND DEVELOPMENT OF NEW PRODUCTS
  • R+D+I
    • DEVELOPMENT OF VACCINES
    • DIVA VACCINES
    • IN VITRO AND IN VIVO MODELS & DRUG SCREENING
  • NEWS
  • WHO ARE WE?
  • CONTACT US
  • ESPAÑOL